Main menu button

News

Carlsquare advised Flybotix on its USD 10M Series A Financing
03 sep 2025
Carlsquare advised Flybotix on its USD 10M Series A Financing
Deal News
Carlsquare advised Deutsche Beteiligungs AG on the acquisition of MAIT Group from 3i Group
03 sep 2025
Carlsquare advised Deutsche Beteiligungs AG on the acquisition of MAIT Group from 3i Group
Deal News
Research update Biosergen: Ongoing development going according to plan
02 sep 2025
Research update Biosergen: Ongoing development going according to plan
Equity Research Biosergen
Equity Research Enrad, Q2 2025: Investments and growth according to plan
02 sep 2025
Equity Research Enrad, Q2 2025: Investments and growth according to plan
Equity Research Enrad
Equity research Zinzino Q2 2025: Subscribing to rapid growth
02 sep 2025
Equity research Zinzino Q2 2025: Subscribing to rapid growth
Equity Research Zinzino
Carlsquare advised the shareholders of Buben & Mädchen GmbH on the sale to Awardit AB
01 sep 2025
Carlsquare advised the shareholders of Buben & Mädchen GmbH on the sale to Awardit AB
Deal News
Equity research Zinzino Q2 2025: Video interview with CEO Dag Bergheim Pettersen
01 sep 2025
Equity research Zinzino Q2 2025: Video interview with CEO Dag Bergheim Pettersen
Equity Research Zinzino
Equity research Viva Wine Group, Q2 2025: Soft markets, but expansion is underway
01 sep 2025
Equity research Viva Wine Group, Q2 2025: Soft markets, but expansion is underway
Equity Research Viva Wine Group
Equity research Zinzino Q2, 2025: Expansion costs hamper margins, but strong outlook
29 aug 2025
Equity research Zinzino Q2, 2025: Expansion costs hamper margins, but strong outlook
Equity Research Zinzino
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
28 aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Equity Research Immunovia
Equity Research Svenska Aerogel, Q2 2025: Strong growth, but lower than expected revenues
28 aug 2025
Equity Research Svenska Aerogel, Q2 2025: Strong growth, but lower than expected revenues
Equity Research Svenska Aerogel
Equity research Viva Wine Group Q2, 2025: Stable performance in a soft market
28 aug 2025
Equity research Viva Wine Group Q2, 2025: Stable performance in a soft market
Equity Research Viva Wine Group
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
27 aug 2025
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
Equity Research Nosa Plugs
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
25 aug 2025
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
Equity Research Elicera Therapeutics
Equity research, White Pearl Technology Group: A hidden gem among the tech companies
21 aug 2025
Equity research, White Pearl Technology Group: A hidden gem among the tech companies
Equity Research White Pearl Technology Group
Carlsquare Global Tech Summit 2025
20 aug 2025
Carlsquare Global Tech Summit 2025
Events
Equity Research KlaraBo: The option programme demonstrates a strong commitment
19 aug 2025
Equity Research KlaraBo: The option programme demonstrates a strong commitment
Equity Research KlaraBo
Carlsquare advised Boomi on the acquisition of Thru
14 aug 2025
Carlsquare advised Boomi on the acquisition of Thru
Deal News
Equity Research Svenska Aerogel: Financing secured through directed issues of units
13 aug 2025
Equity Research Svenska Aerogel: Financing secured through directed issues of units
Equity Research Svenska Aerogel
Equity research Viva Wine Group, Q2 2025: No market tailwind but support from Delta acquisition
11 aug 2025
Equity research Viva Wine Group, Q2 2025: No market tailwind but support from Delta acquisition
Equity Research Viva Wine Group